The screening of immune-related biomarkers for prognosis of lung adenocarcinoma

Lung adenocarcinoma (LUAD) accounts for a frequently seen non-small cell lung cancer (NSCLC) histological subtype, and it is associated with dismal prognostic outcome. However, the benefits of traditional treatment are still limited, and the efficacies of immunotherapy are quite different. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhonghui, Sun, Dan, Zhu, Qing, Liu, Xinmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806236/
https://www.ncbi.nlm.nih.gov/pubmed/33870858
http://dx.doi.org/10.1080/21655979.2021.1911211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806236/
https://www.ncbi.nlm.nih.gov/pubmed/33870858
http://dx.doi.org/10.1080/21655979.2021.1911211

Ejemplares similares